Leading policy-makers and scholars explain how market forces, deregulation, and consumer choice can work to improve health care for all Americans.


Delivering on the AIDS fight
Chicago Tribune, 1-28-05

The Tribune praises President Bush for his ongoing commitment to fighting AIDS in developing nations, including the recent FDA approval of the first generic combination AIDS drug for purchase by the Presidents Emergency Plan for AIDS Relief. Says the Tribune: “No other president, or country, has done more to fight AIDS worldwide than Bush and the U.S.”

A cornerstone of the President’s plan has been the demand that generic medicines used to fight the disease should meet the same standards that we use to evaluate patented drugs sold in the U.S., and the FDA has responded by promising to evaluate data submitted by generic manufacturers quickly and free of charge. Other generic companies should follow suit and patient advocate groups should get over their fruitless sniping against research driven pharmaceutical companies.

The battle against AIDS in developing nations is a two-front war where both generic and patented medicines have critical roles to play in overcoming the disease.

Project FDA.
home   spotlight   commentary   research   events   news   about   contact   links   archives
Copyright Manhattan Institute for Policy Research
52 Vanderbilt Avenue
New York, NY 10017
(212) 599-7000